New Zealand markets close in 29 minutes

AnPac Bio-Medical Science Co Ltd (0UC0.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
0.30800.0000 (0.00%)
At close: 08:04AM CEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,980
12,044
17,986
20,509
10,845
Cost of revenue
7,747
3,708
5,732
7,628
6,047
Gross profit
9,233
8,336
12,254
12,881
4,798
Operating expenses
Research development
11,835
9,532
16,204
11,576
9,839
Selling general and administrative
116,062
82,942
102,096
94,431
82,721
Total operating expenses
127,897
92,474
118,300
106,007
92,560
Operating income or loss
-118,664
-84,138
-106,046
-93,126
-87,762
Interest expense
651
373
4,257
1,143
2,609
Total other income/expenses net
-20,917
-21,217
-10,964
13,616
-11,468
Income before tax
-140,232
-105,728
-121,267
-80,653
-101,839
Income tax expense
-2,209
-2,130
-1,180
-88
-218
Income from continuing operations
-138,023
-103,598
-120,087
-80,565
-101,621
Net income
-124,582
-101,893
-118,695
-80,475
-101,060
Net income available to common shareholders
-124,582
-101,893
-118,695
-80,475
-101,060
Basic EPS
-23.80
-53.20
-174.40
-143.80
-204.82
Diluted EPS
-23.80
-53.20
-174.40
-143.80
-204.82
Basic average shares
4,431
1,912
680.276
559.504
493.4
Diluted average shares
4,431
1,912
680.276
559.504
493.4